CSTM

Constellium SE

71
Fundamentals71/ 100
Valuation83/ 100
Upside potential59/ 100
Risk potential20/ 100

CSTM's fundamentals are strong and it looks cheap: trading at 5.5x earnings, about half its usual 12x. Analysts expect earnings to hold roughly steady.

CSTM Fundamentals

MetricStatus
Healthy
Healthy
Stable
Healthy

CSTM's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.

CSTM PE Valuation

CHEAPFAIREXPENSIVE59x119x178x238x
CHEAPFAIREXPENSIVE59x119x178x238x
LevelPEPriceVs current
Current5.5x$22.59—
Cheap6.7x$27.51+22%
Forward8.6x$22.59—
Fair12x$48.94+117%
Expensive26x$106+369%

Historical ranges are pointers, not guarantees.

CSTM's PE is in its cheap range at 5.5x. On analysts' estimates for next year's earnings, today's price would be 8.6x.

CSTM Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Stable
Stable
Limited
Moderate

Analysts expect CSTM's earnings, revenue and profitability to hold roughly steady.

CSTM Risk to reward

ScenarioChangePrice
Upside+29%$29.04
Downside-20%$18.09

Calculated from the latest close: $22.59 on Nov 12.

CSTM's one-year upside scenario is somewhat larger than its downside: +29% against −20%.

CSTM Earnings Per Share

Q4 2023: $0.88Q1 2024: $0.85Q2 2024: $1.15Q3 2024: $0.69Q4 2024: $0.40Q1 2025: $0.54Q2 2025: $0.26Q3 2025: $0.86Q4 2025: $1.92Q1 2026: $3.08Q2 2026: $3.87Q3 2026: $4.09Forward: $2.63
Q4 2023: $0.88Q1 2024: $0.85Q2 2024: $1.15Q3 2024: $0.69Q4 2024: $0.40Q1 2025: $0.54Q2 2025: $0.26Q3 2025: $0.86Q4 2025: $1.92Q1 2026: $3.08Q2 2026: $3.87Q3 2026: $4.09Forward: $2.63
QuarterTTM EPSYoY
Forward$2.63-36%
Q3 2026$4.09+376%
Q2 2026$3.87+1388%
Q1 2026$3.08+470%
Q4 2025$1.92+380%
Q3 2025$0.86+25%
Q2 2025$0.26-77%
Q1 2025$0.54-36%
Q4 2024$0.40-55%

CSTM's earnings per share have jumped to their highest in seven years: $4.09 over the past year, up from $0.86 the year before.

CSTM Quarterly Revenue

Q4 2023: $2.3BQ1 2024: $2.1BQ2 2024: $2.1BQ3 2024: $1.8BQ4 2024: $1.7BQ1 2025: $2BQ2 2025: $2.1BQ3 2025: $2.2BQ4 2025: $2.2BQ1 2026: $2.5BQ2 2026: $2.7BQ3 2026: $2.6B
Q4 2023: $2.3BQ1 2024: $2.1BQ2 2024: $2.1BQ3 2024: $1.8BQ4 2024: $1.7BQ1 2025: $2BQ2 2025: $2.1BQ3 2025: $2.2BQ4 2025: $2.2BQ1 2026: $2.5BQ2 2026: $2.7BQ3 2026: $2.6B
QuarterRevenueYoY
Q3 2026$2.6B+22%
Q2 2026$2.7B+31%
Q1 2026$2.5B+24%
Q4 2025$2.2B+31%
Q3 2025$2.2B+19%
Q2 2025$2.1B-2%
Q1 2025$2B-5.2%
Q4 2024$1.7B-26%

CSTM's revenue has grown year over year for five quarters in a row: $2.6B last quarter, up 22% from the same quarter a year ago.

CSTM Free Cash Flow

Q4 2023: −$61MQ1 2024: −$16MQ2 2024: $82MQ3 2024: −$11MQ4 2024: −$162MQ1 2025: −$11MQ2 2025: $37MQ3 2025: $24MQ4 2025: $109MQ1 2026: $1MQ2 2026: $84MQ3 2026: $125M
Q4 2023: −$61MQ1 2024: −$16MQ2 2024: $82MQ3 2024: −$11MQ4 2024: −$162MQ1 2025: −$11MQ2 2025: $37MQ3 2025: $24MQ4 2025: $109MQ1 2026: $1MQ2 2026: $84MQ3 2026: $125M
QuarterFree cash flowYoY
Q3 2026$125M+421%
Q2 2026$84M+127%
Q1 2026$1M+$12M
Q4 2025$109M+$271.1M
Q3 2025$24M+$35.1M
Q2 2025$37M-55%
Q1 2025-$11M+$4.6M
Q4 2024-$162.1M-$100.9M

CSTM's free cash flow has turned positive after two years mostly in the red: $319M over the past year.

CSTM Total Shares

Q4 2023: 149MQ1 2024: 147MQ2 2024: 149MQ3 2024: 147MQ4 2024: 147MQ1 2025: 144MQ2 2025: 142MQ3 2025: 141MQ4 2025: 142MQ1 2026: 140MQ2 2026: 140MQ3 2026: 139M
Q4 2023: 149MQ1 2024: 147MQ2 2024: 149MQ3 2024: 147MQ4 2024: 147MQ1 2025: 144MQ2 2025: 142MQ3 2025: 141MQ4 2025: 142MQ1 2026: 140MQ2 2026: 140MQ3 2026: 139M
PeriodChange %Net change
Quarterly-0.8%-1.2M shares
1 year-1.1%-1.5M shares
3 years-6.5%-9.7M shares
5 years-5.5%-8.2M shares
Available history-2.6%-3.7M shares

CSTM has 139M diluted shares, down 1.1% from a year ago, with $118M in buybacks over the past year.

CSTM Net Leverage

Q4 2023: 2.8xQ1 2024: 3.0xQ2 2024: 2.7xQ3 2024: 2.9xQ4 2024: 3.7xQ1 2025: 3.6xQ2 2025: 4.2xQ3 2025: 3.5xQ4 2025: 2.5xQ1 2026: 1.9xQ2 2026: 1.6xQ3 2026: 1.5x
Q4 2023: 2.8xQ1 2024: 3.0xQ2 2024: 2.7xQ3 2024: 2.9xQ4 2024: 3.7xQ1 2025: 3.6xQ2 2025: 4.2xQ3 2025: 3.5xQ4 2025: 2.5xQ1 2026: 1.9xQ2 2026: 1.6xQ3 2026: 1.5x
QuarterNet LeverageStatus
Q3 20261.5xHealthy
Q2 20261.6xHealthy
Q1 20261.9xHealthy
Q4 20252.5xModerate
Q3 20253.5xElevated
Q2 20254.2xHigh
Q1 20253.6xElevated
Q4 20243.7xElevated

CSTM's net debt is about 1.4 years of its operating earnings (EBITDA), down from 3.5 years a year ago.

CSTM Weekly Momentum

MetricValueStatus
RSI37.2Neutral
Stochastic10.9Oversold

CSTM's weekly RSI is 37 (neutral) and its Stochastic is 11 (oversold).

CSTM PE vs Basic Materials Sector

MetricCSTMSector medianRelative
PE5.5x19x70% below
PE %34037 pts below

CSTM is trading at 5.5x earnings, a 70% discount to the Basic Materials sector's median of 19x.

CSTM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$23.95.5% below
20 week MA$26.414% below
50 week MA$26.414% below
100 week MA$19.516% above
200 week MA$18.324% above

CSTM has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 24% above its 200-week average.

CSTM Yearly ROI

YearStart priceEnd priceROI
2020$13.7$13.6-0.4%
2021$13.6$18.0+32%
2022$18.0$11.8-35%
2023$11.8$20.0+70%
2024$20.0$10.2-49%
2025$10.2$19.0+86%
2026 YTD$19.0$22.6+19%

CSTM has finished lower in three of the last six years. It's up 19% so far in 2026.

Give your agent the market.

Get API key